Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 32
Results: 9
Pulmonary pleomorphic carcinoma treated with PD‐1 inhibitor: Two case reports.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3240, doi. 10.1111/1759-7714.15120
- By:
- Publication type:
- Article
Radiofrequency ablation for stage <IIB non‐small cell lung cancer: Opportunities, challenges, and the road ahead.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3181, doi. 10.1111/1759-7714.15114
- By:
- Publication type:
- Article
Bronchoscopy for management and identification of etiology of right middle lobe syndrome: Analysis of 66 cases.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3226, doi. 10.1111/1759-7714.15113
- By:
- Publication type:
- Article
A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3232, doi. 10.1111/1759-7714.15115
- By:
- Publication type:
- Article
Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3217, doi. 10.1111/1759-7714.15112
- By:
- Publication type:
- Article
Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta‐analysis of real‐world survival outcomes of East Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR‐TKIs
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3208, doi. 10.1111/1759-7714.15111
- By:
- Publication type:
- Article
Altered functional connectivity of the nucleus tractus solitarii in patients with chronic cough after lung surgery: an rs‐fMRI study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3202, doi. 10.1111/1759-7714.15110
- By:
- Publication type:
- Article
Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3191, doi. 10.1111/1759-7714.15109
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 32, p. 3179, doi. 10.1111/1759-7714.14518
- Publication type:
- Article